Belimumab, referred to as LymphoStat B, represents a unique therapy for autoimmune diseases, particularly systemic lupus erythematosus. This monoclonal antibody specifically targets B cell activating factor, a key https://idamkmt078766.aboutyoublog.com/52453148/belimumab-understanding-lymphostat-β-and-its-significance